Oral sodium bicarbonate

DRUG5 trials

Conditions

Acute Kidney InjuryChronic HemodialysisContrast Induced NephropathyContrast Media ReactionEnd Stage Renal Disease (ESRD)End-stage Renal Disease (ESRD)Labour DystociaMetabolic Acidosis

Phase 1

the Effect of Interdialytic Serum Bicarbonate Correction on Vascular Calcification in Hemodialysis Patients

CompletedNCT07765459

Ain Shams UniversityEnd Stage Renal Disease (ESRD), Metabolic Acidosis

Start: 2023-09-01End: 2024-02-29Updated: 2026-08-14

Phase 3

PrevenTion of Contrast-inducEd nephroAThy With urinE Alkalinization

CompletedNCT02980003

G. d'Annunzio UniversityAcute Kidney Injury, Contrast Media Reaction

Start: 2015-03-31End: 2021-05-01Updated: 2022-05-23

Phase 4

Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy

WithdrawnNCT01093131

The Western Pennsylvania HospitalContrast Induced Nephropathy

Start: 2005-02-28End: 2010-02-28Updated: 2019-10-04

Unknown Phase

Oral Sodium Bicarbonate for the Prevention of Labour Dystocia

Not yet recruitingNCT06249061

Liz DarlingLabour Dystocia

Start: 2025-12-31End: 2027-12-31Target: 200Updated: 2025-07-23

Pilot Trial of Oral Sodium Bicarbonate Versus Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis

Not yet recruitingNCT07688434

University of SfaxEnd-stage Renal Disease (ESRD), Chronic Hemodialysis, Metabolic Acidosis

Start: 2026-07-01End: 2026-09-01Target: 37Updated: 2026-07-21

Related Papers

Urine alkalinisation to prevent contrast-induced acute kidney injury: the prospective, randomised, controlled, open-label TEATE trial

EuroIntervention2022-09-016 citations

651 Prevention of contrast induced nephropathy with urine alkalinization: the final results of the TEATE study

European Heart Journal Supplements2021-12-01